Is Vitamin K2 worth it?
Vitamin K is essential, but K2 is not a substantiated hormone optimizer. Bone and vascular-calcification marketing is already more mixed than ads imply, and testosterone or hormonal-balance claims do not clear the evidence bar.
The call
NIH ODS treats vitamin K as a family of essential vitamers for clotting and vitamin-K-dependent proteins, without a separate U.S. intake target for K2. Clinical evidence around supplemental vitamin K and bone outcomes is mixed and population-dependent, and that is still not the same as a hormone verdict. The common hormone-stack pitch jumps from mechanisms to outcomes without human endpoint support. For a typical buyer, K2 belongs in food or clinician-directed bone/cardiometabolic care, not a hormonal optimization cart.
Safety
The central safety issue is anticoagulation: vitamin K can counteract warfarin and other vitamin K antagonists, so intake should be consistent and clinician-managed. People taking bile acid sequestrants, orlistat, mineral oil, certain antibiotics, or anticonvulsants may need medical guidance because vitamin K status or absorption can be affected. Use clinician oversight with fat-malabsorption disorders, liver or biliary disease, pregnancy, lactation, or before surgery. Avoid menadione or vitamin K3 products; they are not appropriate human dietary supplements.
Dose that matters: For basic nutrition, aim for total vitamin K adequate intake from food: 120 mcg/day for adult men and 90 mcg/day for adult women. If a clinician recommends K2 for a bone-oriented reason, MK-7 products commonly sit around 90-180 mcg/day, but that is not a hormone dose. Do not self-adjust vitamin K intake while taking warfarin or another vitamin K antagonist.
Sources
Tier 1 · evidence synthesis · Reviewed by the Stack-kit desk